(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | -37.86%162.67M | 1.37%507.06M | -23.70%261.76M | 25.70%500.19M | --343.09M | 50.42%397.91M | --264.53M |
Operating income | -37.86%162.67M | 1.37%507.06M | -23.70%261.76M | 25.70%500.19M | 343.09M | 50.42%397.91M | 264.53M |
Cost of sales | 11.33%-57.36M | -10.33%-180.98M | 13.33%-64.7M | 34.04%-164.04M | ---74.65M | -34.54%-248.72M | ---184.86M |
Operating expenses | 11.33%-57.36M | -10.33%-180.98M | 13.33%-64.7M | 34.04%-164.04M | -74.65M | -34.54%-248.72M | -184.86M |
Gross profit | -46.56%105.31M | -3.00%326.08M | -26.59%197.07M | 125.31%336.15M | 268.44M | 87.26%149.2M | 79.67M |
Selling expenses | -52.34%-91.29M | -55.18%-150.71M | -40.09%-59.93M | 8.32%-97.12M | ---42.78M | -42.15%-105.94M | ---74.53M |
Administrative expenses | -26.65%-55.88M | -61.30%-88.99M | -74.59%-44.12M | -13.28%-55.17M | ---25.27M | 6.77%-48.7M | ---52.24M |
Research and development expenses | 23.14%-55.81M | -30.41%-154.75M | -39.19%-72.62M | -29.68%-118.66M | ---52.18M | 5.76%-91.51M | ---97.09M |
Impairment and provision | 82.14%255K | -225.10%-3.89M | 165.73%140K | -159.22%-1.2M | ---213K | -476.25%-461K | ---80K |
-Other impairment is provision | 82.14%255K | -225.10%-3.89M | 165.73%140K | -159.22%-1.2M | ---213K | -476.25%-461K | ---80K |
Special items of operating profit | -105.65%-694K | 225.79%24.71M | 196.02%12.28M | -78.73%7.58M | --4.15M | 299.08%35.65M | --8.93M |
Operating profit | -399.00%-98.12M | -166.41%-47.54M | -78.43%32.82M | 215.92%71.59M | 152.15M | 54.37%-61.76M | -135.33M |
Financing cost | -2.40%-171K | 74.78%-253K | 68.67%-167K | 0.50%-1M | ---533K | 61.51%-1.01M | ---2.62M |
Share of profit from joint venture company | ---- | ---- | ---- | 49.58%-9.36M | ---9.36M | 37.71%-18.57M | ---29.81M |
Special items of earning before tax | -92.76%-480.46M | -1.09%-753.01M | 30.25%-249.25M | -653.24%-744.91M | ---357.37M | -138.29%-98.89M | --258.29M |
Earning before tax | -167.19%-578.75M | -17.13%-800.81M | -0.69%-216.6M | -279.35%-683.68M | -215.11M | -299.09%-180.23M | 90.53M |
Tax | 99.37%-11K | -38.50%-1.8M | -78.85%-1.74M | 26.07%-1.3M | ---974K | -3,146.30%-1.75M | ---54K |
After-tax profit from continuing operations | -165.07%-578.76M | -17.17%-802.6M | -1.05%-218.34M | -276.40%-684.98M | -216.09M | -301.14%-181.98M | 90.47M |
After-tax profit from non-continuing business | ---- | ---- | ---- | 116.09%15.17M | --15.17M | -174.76%-94.32M | ---34.33M |
Earning after tax | -165.07%-578.76M | -19.83%-802.6M | -8.68%-218.34M | -142.42%-669.81M | -200.91M | -592.10%-276.3M | 56.15M |
Profit attributable to shareholders | -165.07%-578.76M | -19.83%-802.6M | -8.68%-218.34M | -142.42%-669.81M | -200.91M | -592.10%-276.3M | 56.15M |
Basic earnings per share | -83.33%-0.55 | -0.3 | |||||
Diluted earnings per share | -83.33%-0.55 | -0.3 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data